Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling

J Mol Cell Cardiol. 2018 Mar:116:135-144. doi: 10.1016/j.yjmcc.2018.02.006. Epub 2018 Feb 10.

Abstract

Cardiac fibrosis is characterized by excessive deposition of extracellular matrix (ECM) proteins in the myocardium and results in decreased ventricular compliance and diastolic dysfunction. Cartilage intermediate layer protein-1 (CILP-1), a novel identified cardiac matricellular protein, is upregulated in most conditions associated with cardiac remodeling, however, whether CILP-1 is involved in pressure overload-induced fibrotic response is unknown. Here, we investigated whether CILP-1 was critically involved in the fibrotic remodeling induced by pressure overload. Western blot analysis and immunofluorescence staining showed that CILP-1 was predominantly detected in cardiac myocytes and to a less extent in the interstitium. In isolated adult mouse ventricular myocytes and nonmyocytes, CILP-1 was found to be mainly synthesized by myocytes. CILP-1 expression in left ventricles was upregulated in C57BL/6 mice undergoing transverse aortic constriction (TAC). Myocardial CILP-1 knockdown aggravated whereas CILP-1 overexpression attenuated TAC-induced ventricular remodeling and dysfunction, as measured by echocardiography test, morphological examination, and gene expressions of fibrotic molecules. Incubation of cardiac fibroblasts with the conditioned medium containing full-length, N-terminal, or C-terminal CILP-1 inhibited transforming growth factor (TGF)-β1-induced Smad3 phosphorylation and the subsequent profibrotic events. We first demonstrated that C-terminal CILP-1 increased Akt phosphorylation, promoted the interaction between Akt and Smad3, and suppressed Smad3 phosphorylation. Blockade of PI3K-Akt pathway attenuated the inhibitory effect of C-CILP-1 on TGF-β1-induced Smad3 activation. We conclude that CILP-1 is a novel ECM protein possessing anti-fibrotic ability in pressure overload-induced fibrotic remodeling. This anti-fibrotic effect of CILP-1 attributes to interfering TGF-β1 signaling through its N- and C- terminal fragments.

Keywords: Cardiac fibrosis; Cartilage intermediate layer protein-1; Pressure overload; Smad3; Transforming growth factor-β1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / diagnostic imaging
  • Aorta / pathology
  • Aorta / physiopathology
  • Constriction, Pathologic
  • Dependovirus / metabolism
  • Fibrosis
  • Gene Knockdown Techniques
  • Mice, Inbred C57BL
  • Myocardium / metabolism*
  • Myocardium / pathology*
  • Myocytes, Cardiac / metabolism
  • Phosphorylation
  • Pressure*
  • Protein Binding
  • Proto-Oncogene Proteins c-akt / metabolism
  • Pyrophosphatases / genetics
  • Pyrophosphatases / metabolism*
  • Signal Transduction*
  • Smad3 Protein / metabolism
  • Transforming Growth Factor beta1 / metabolism*
  • Up-Regulation / genetics
  • Ventricular Remodeling

Substances

  • Smad3 Protein
  • Transforming Growth Factor beta1
  • Proto-Oncogene Proteins c-akt
  • CILP protein, mouse
  • Pyrophosphatases